Adagene (ADAG) Earnings Date & Reports

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ADAG is expected to report earnings to rise 30.23% to -28 cents per share on December 02

Q3'26

Est.

$-0.28

Q2'26

Missed

by $0.03

Q1'26

Beat

by $0.15

Q4'25

Beat

by $0.15

Q2'25

Beat

by $0.10

The last earnings report on August 12 showed earnings per share of -21 cents, missing the estimate of -18 cents. With 143.30K shares outstanding, the current market capitalization sits at 200.09M.

View a ticker or compare two or three

ADAG

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ADAG